|
PREPL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56739074444567E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.70672373403613E-12 |
| Normal-vs-Stage2 |
6.82409999952505E-07 |
| Normal-vs-Stage3 |
2.72309952364935E-10 |
| Normal-vs-Stage4 |
1.931740E-02 |
| Stage1-vs-Stage2 |
5.561000E-01 |
| Stage1-vs-Stage3 |
9.594400E-01 |
| Stage1-vs-Stage4 |
3.641800E-01 |
| Stage2-vs-Stage3 |
5.656400E-01 |
| Stage2-vs-Stage4 |
6.855400E-01 |
| Stage3-vs-Stage4 |
4.854600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.03723712846704E-12 |
| Normal-vs-AfricanAmerican |
2.50629961229265E-10 |
| Normal-vs-Asian |
1.122400E-01 |
| Caucasian-vs-AfricanAmerican |
8.435000E-01 |
| Caucasian-vs-Asian |
5.027800E-01 |
| AfricanAmerican-vs-Asian |
5.778800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.84190000002338E-06 |
| Male-vs-Female |
1.095200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.4076999566015E-09 |
| Normal-vs-Extreme_Weight |
1.82398540715667E-12 |
| Normal-vs-Obese |
2.11020000362439E-08 |
| Normal-vs-Extreme_Obese |
1.432680E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.382600E-01 |
| Normal_Weight-vs-Obese |
3.206400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.619600E-01 |
| Extreme_Weight-vs-Obese |
4.164200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.815000E-01 |
| Obese-vs-Extreme_Obese |
9.917400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.07049999999542E-05 |
| Normal-vs-Age(41-60Yrs) |
2.26849983242516E-10 |
| Normal-vs-Age(61-80Yrs) |
4.41868763800812E-14 |
| Normal-vs-Age(81-100Yrs) |
6.11379999959638E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.087200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.575840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.566000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.264500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.579200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.221800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64812608005604E-12 |
| Normal-VS-Type2 PRCC |
1.19779963725364E-10 |
| Normal-VS-KIRP CIMP |
6.570700E-04 |
| Normal-VS-Unclassified PRCC |
2.29399999999158E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.970200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.537400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.898620E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.205400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.094200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.794800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.22533144426052E-13 |
| Normal-vs-N1 |
4.11860000000264E-05 |
| Normal-vs-N2 |
7.882200E-03 |
| N0-vs-N1 |
4.691600E-02 |
| N0-vs-N2 |
4.556600E-01 |
| N1-vs-N2 |
8.262000E-01 |
|
|
